Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma

被引:44
作者
Akita, Masayuki [1 ,2 ]
Sofue, Keitaro [3 ]
Fujikura, Kohei [2 ]
Otani, Kyoko [2 ]
Itoh, Tomoo [2 ]
Ajiki, Tetsuo [1 ]
Fukumoto, Takumi [1 ]
Zen, Yoh [2 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo 6500017, Japan
[3] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan
关键词
ACUTE MYELOID-LEUKEMIA; SURGICAL-TREATMENT; MANAGEMENT; INHIBITOR; DIFFERENTIATION; IMPACT; MDM2;
D O I
10.1016/j.hpb.2018.07.021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Growing evidence has suggested that intrahepatic cholangiocarcinoma (iCCA) can be classified into small- and large-duct types. The present study aimed to elucidate how large-duct iCCA is similar and dissimilar to perihilar cholangiocarcinoma (pCCA). Methods: The study cohort consisted of iCCA (n = 58) and pCCA (n = 44). After iCCA tumors were separated into small- (n = 36) and large-duct (n = 22) types based on our histologic criteria, genetic statuses of the three types of neoplasms were compared. Locations of iCCA were plotted on a three-dimensional image and their distances from the portal bifurcation were measured. Results: Large-duct iCCA was distinct from small-duct iCCA in terms of frequency of bile duct reconstruction required, perineural infiltration, and survival, with these features more similar to pCCA. Large-duct iCCA and pCCA more frequently had the loss of SMAD4 expression and MDM2 amplifications than small-duct iCCA, whereas the loss of BAP1 expression and IDH1 mutations were mostly restricted to small-duct iCCA. From imaging analysis, most tumors of large-duct iCCA were present around the second branches of the portal vein. Conclusion: Large-duct type iCCA shared the molecular features with pCCA, and it may be reasonable to expand the definition of pCCA to include cancers originating from the second bile duct branches.
引用
收藏
页码:226 / 234
页数:9
相关论文
共 28 条
  • [1] Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery
    Adachi, Tomohiko
    Eguchi, Susumu
    Beppu, Toru
    Ueno, Shinichi
    Shiraishi, Masayuki
    Okuda, Koji
    Yamashita, Yo-ichi
    Kondo, Kazuhiro
    Nanashima, Atsushi
    Ohta, Masayuki
    Takami, Yuko
    Noritomi, Tomoaki
    Kitahara, Kenji
    Fujioka, Hikaru
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) : 2269 - 2278
  • [2] Proposal of progression model for intrahepatic cholangiocarcinoma: Clinicopathologic differences between hilar type and peripheral type
    Aishima, Shinichi
    Kuroda, Yousuke
    Nishihara, Yunosuke
    Iguchi, Tomohiro
    Taguchi, Kenichi
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Tsuneyoshi, Masazumi
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (07) : 1059 - 1067
  • [3] Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas
    Akita, Masayuki
    Fujikura, Kohei
    Ajiki, Tetsuo
    Fukumoto, Takumi
    Otani, Kyoko
    Azuma, Takeshi
    Itoh, Tomoo
    Ku, Yonson
    Zen, Yoh
    [J]. MODERN PATHOLOGY, 2017, 30 (07) : 986 - 997
  • [4] Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response
    Amatangelo, Michael D.
    Quek, Lynn
    Shih, Alan
    Stein, Eytan M.
    Roshal, Mikhail
    David, Muriel D.
    Marteyn, Benoit
    Farnoud, Noushin Rahnamay
    de Botton, Stephane
    Bernard, Olivier A.
    Wu, Bin
    Yen, Katharine E.
    Tallman, Martin S.
    Papaemmanuil, Elli
    Penard-Lacronique, Virginie
    Thakurta, Anjan
    Vyas, Paresh
    Levine, Ross L.
    [J]. BLOOD, 2017, 130 (06) : 732 - 741
  • [5] Assessment of Nodal Status for Perihilar Cholangiocarcinoma Location, Number, or Ratio of Involved Nodes
    Aoba, Taro
    Ebata, Tomoki
    Yokoyama, Yukihiro
    Igami, Tsuyoshi
    Sugawara, Gen
    Takahashi, Yu
    Nimura, Yuji
    Nagino, Masato
    [J]. ANNALS OF SURGERY, 2013, 257 (04) : 718 - 725
  • [6] SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma
    Bill, Kate Lynn J.
    Garnett, Jeannine
    Meaux, Isabelle
    Ma, XiaoYen
    Creighton, Chad J.
    Bolshakov, Svetlana
    Barriere, Cedric
    Debussche, Laurent
    Lazar, Alexander J.
    Prudner, Bethany C.
    Casadei, Lucia
    Braggio, Danielle
    Lopez, Gonzalo
    Zewdu, Abbie
    Bid, Hemant
    Lev, Dina
    Pollock, Raphael E.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (05) : 1150 - 1160
  • [7] Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120
    Birendra, K. C.
    DiNardo, Courtney D.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (08) : 460 - 465
  • [8] MANAGEMENT STRATEGIES IN RESECTION FOR HILAR CHOLANGIOCARCINOMA
    BISMUTH, H
    NAKACHE, R
    DIAMOND, T
    [J]. ANNALS OF SURGERY, 1992, 215 (01) : 31 - 38
  • [9] Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
    Bridgewater, John
    Galle, Peter R.
    Khan, Shahid A.
    Llovet, Josep M.
    Park, Joong-Won
    Patel, Tushar
    Pawlik, Timothy M.
    Gores, Gregory J.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1268 - 1289
  • [10] The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival
    Choi, Sae-Byeol
    Kim, Kyung-Sik
    Choi, Jin-Young
    Park, Seung-Woo
    Choi, Jin-Sub
    Lee, Woo-Jung
    Chung, Jae-Bock
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (11) : 3048 - 3056